Rocket


Overview
Financials
News + Filings
Key Docs
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Praxis Precision Medicines, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
12/01/2020 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Praxis Precision Medicines Announces CFO Transition CAMBRIDGE, Mass., Dec. 01, 2020 - Praxis Precision Medicines, Inc. , a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance, today announced that Stuart Chaffee, Ph.D., will be transitioning from his current position as the Company's chief financial officer to a part-time role as a strategic advisor to Praxis. The Company has commenced a search for a full-time chief financial officer. Lauren Mastrocola, the Company's vice president of finance and principal accounting officer, has assumed the responsibilities of principal financial officer on an interim basis. “I'm incredibly proud of what we've built at Praxis and co..."
11/23/2020 10-Q Quarterly Report for the period ended September 30, 2020
11/17/2020 8-K Other Events, Financial Statements and Exhibits
Docs: "Praxis Precision Medicines Provides Update On PRAX-114 IND Submission For The Treatment Of Major Depressive Disorder"
11/10/2020 4 Souza Marcio (CEO) has filed a Form 4 on Praxis Precision Medicines, Inc.
Txns: Bought 3,846 shares @ $26.08, valued at $100.3k
11/04/2020 4 Mastrocola Lauren (Principal Accounting Officer) has filed a Form 4 on Praxis Precision Medicines, Inc.
Txns: Exercised 12,218 options to buy @ $3.3, valued at $40.3k
10/22/2020 4 BSOF Parallel Master Fund L.P. (10% Owner) has filed a Form 4 on Praxis Precision Medicines, Inc.
Txns: Converted 3,446,711 shares @ $0
Converted 2,361,198 shares @ $0
Converted 659,116 shares @ $0
Converted 261,318 shares @ $0
Converted 907,378 shares @ $0
Converted 164,832 shares @ $0
Converted 7,375,799 options to buy @ $0
Converted 5,052,852 options to buy @ $0
Converted 1,410,477 options to buy @ $0
Converted 559,208 options to buy @ $0
Converted 1,941,748 options to buy @ $0
10/22/2020 4 Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 4 on Praxis Precision Medicines, Inc.
Txns: Converted 3,446,711 shares @ $0
Converted 2,361,198 shares @ $0
Converted 659,116 shares @ $0
Converted 261,318 shares @ $0
Converted 907,378 shares @ $0
Converted 164,832 shares @ $0
Converted 7,375,799 options to buy @ $0
Converted 5,052,852 options to buy @ $0
Converted 1,410,477 options to buy @ $0
Converted 559,208 options to buy @ $0
Converted 1,941,748 options to buy @ $0
10/21/2020 4 Novo Holdings A/S (10% Owner) has filed a Form 4 on Praxis Precision Medicines, Inc.
Txns: Converted 2,442,080 shares @ $0
Converted 4,150,000 options to buy @ $0
Converted 551,794 options to buy @ $0
Converted 171,410 options to buy @ $0
Converted 352,734 options to buy @ $0
10/20/2020 4 Souza Marcio (CEO) has filed a Form 4 on Praxis Precision Medicines, Inc.
Txns: Converted 20,604 shares @ $0
Converted 44,092 options to buy @ $0
10/20/2020 4 Vitorovic Stefan (Director) has filed a Form 4 on Praxis Precision Medicines, Inc.
Txns: Converted 2,689,329 shares @ $0
Converted 4,150,000 preferred shares @ $0
Converted 551,794 options to buy @ $0
Converted 171,410 preferred shares @ $0
Converted 881,835 options to buy @ $0
10/20/2020 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Amended and Restated Certificate of Incorporation of Praxis Precision Medicines, Inc",
"Amended and Restated Bylaws of Praxis Precision Medicines, Inc"
10/16/2020 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
10/16/2020 424B4 Form 424B4 - Prospectus [Rule 424(b)(4)]:
10/16/2020 EFFECT Form EFFECT - Notice of Effectiveness:
10/15/2020 3 Clarus Lifesciences III, L.P. (10% Owner) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 3 BSOF Parallel Master Fund L.P. (10% Owner) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 3 Novo Holdings A/S (10% Owner) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 3 Vitorovic Stefan (Director) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 3 Souza Marcio (CEO) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 3 Norden Gregory (Director) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 3 GALAKATOS NICHOLAS (Director) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 3 Ravina Bernard (Chief Medical Officer) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 3 Chaffee Stuart (CFO) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 3 Reddy Kiran (Director) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 3 MITCHELL DEAN J (Director) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 3 Mastrocola Lauren (Principal Accounting Officer) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 3 Nemiroff Alex (General Counsel and Secretary) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 3 Sweeny Nicole (Chief Commercial Officer) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 3 YOUNG WILLIAM D (Director) has filed a Form 3 on Praxis Precision Medicines, Inc.
10/15/2020 CERT Form CERT - Certification by an exchange approving securities for listing:
10/15/2020 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
10/14/2020 8-A12B Form 8-A12B - Registration of securities [Section 12(b)]:
10/09/2020 S-1/A Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
09/25/2020 S-1 Form S-1 - General form for registration of securities under the Securities Act of 1933:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy